European Lithium’s Greenland Offtake and Cash Infusion Fail to Close Merger Valuation Gap

European Lithium shares trade at A$0.415, well below deal value, as Greenland rare earth project advances but Austrian lithium setback and governance issues weigh on investor confidence.

Despite a binding merger agreement, a freshly secured offtake contract for Greenland’s rare earths, and a cash position that has blown past a critical threshold, European Lithium’s stock continues to trade at a steep discount to the implied value of the deal. The disconnect between contract and confidence remains stark.

Shares last changed hands on the ASX at A$0.415, some 40% below the A$0.58 per-share value embedded in the merger ratio with Critical Metals Corp. That ratio — 0.035 Critical Metals shares for each European Lithium share — has created a headline premium of 137% above the price before the initial offer, but the market is clearly not buying the paper arithmetic. Critical Metals itself slipped nearly 7% to $9.80 on the day after the announcement, adding to the skepticism.

A rare earths bonanza in Greenland, but regulatory clouds gather

The Tanbreez project in Greenland is the centrepiece of the combined group’s future. Critical Metals has already locked up a 15-year offtake agreement with REalloys Inc. for 15% of annual rare earth concentrate production, with preferential rights to key heavy rare earths such as dysprosium and terbium. That contract, signed on 21 May 2026, formalises a letter of intent from October 2025 and brings total offtake coverage to roughly 75% of expected Tanbreez output. The resource itself stands at about 45 million tonnes, of which 27% is heavy rare earths — a composition that will become strategic for US defence supply chains from 2027, when new procurement rules exclude Chinese sources. Phase 1 calls for up to 15,000 tonnes of concentrate per year, with commercial production of dysprosium, terbium and neodymium targeted for January 2027.

Yet on the other side of the Atlantic, European Lithium’s Austrian flagship, the Wolfeberg lithium project, hit a serious regulatory setback. Austria’s Federal Administrative Court overturned a key environmental permit, pushing the final investment decision to at least the end of 2026. The company is quick to point out that the mining licence and a supply contract with BMW remain intact.

Cash condition met, but governance concerns persist

One major hurdle has been cleared: European Lithium sold shares in Critical Metals to raise roughly A$45 million, boosting its cash pile to about A$356 million. That comfortably exceeds the A$330 million minimum required under the merger terms — a liquidity clause that had been a flashpoint for investors. The earlier cash position, before the sale, stood at around A$306 million.

But two governance issues continue to unnerve shareholders. The ASX has launched a formal investigation into whether European Lithium breached its disclosure obligations. The company disputes the claim, pointing to the timing of the binding agreement. Additionally, Tony Sage serves as both executive chairman of European Lithium and CEO of Critical Metals, raising obvious conflict-of-interest questions. An independent committee set up to review the deal has recommended approval — but only if no superior bid emerges and a fairness opinion clears the terms. Approval itself is a high bar: under Australian law, the deal requires a majority of voting shareholders by headcount plus at least 75% by value.

Timeline and next steps

The scheme booklet is expected to be dispatched in July or August, with shareholder meetings pencilled in for August or September. Subsequent court and regulatory approvals in Australia would follow, and if everything stays on track, the merger could close in the second half of 2026.

The liquidity crunch is over. But the ASX probe, the Austrian permitting fight, and the dual-role conflict have not gone away. Until those question marks shrink, the paper value of the merger offer will remain just that — paper.